Wired: Big Pharma is About to Tune in to the Potential of Psychedelics

Summary: Robin Carhart-Harris, Ph.D., Director and Head of the Centre for Psychedelic Research at Imperial College London, reviews achievements from the field of psychedelic science in 2020 and offers perspective about how research may evolve this year. “2021 will be the time that psychedelic therapy casts a spotlight on the limitations of current mental-health care treatments, and highlights a bold alternative,” explains Dr. Carhart-Harris.

Originally appearing here.